These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 26751771)
1. CFTR is a tumor suppressor gene in murine and human intestinal cancer. Than BL; Linnekamp JF; Starr TK; Largaespada DA; Rod A; Zhang Y; Bruner V; Abrahante J; Schumann A; Luczak T; Walter J; Niemczyk A; O'Sullivan MG; Medema JP; Fijneman RJ; Meijer GA; Van den Broek E; Hodges CA; Scott PM; Vermeulen L; Cormier RT Oncogene; 2016 Aug; 35(32):4179-87. PubMed ID: 26751771 [TBL] [Abstract][Full Text] [Related]
2. The role of KCNQ1 in mouse and human gastrointestinal cancers. Than BL; Goos JA; Sarver AL; O'Sullivan MG; Rod A; Starr TK; Fijneman RJ; Meijer GA; Zhao L; Zhang Y; Largaespada DA; Scott PM; Cormier RT Oncogene; 2014 Jul; 33(29):3861-8. PubMed ID: 23975432 [TBL] [Abstract][Full Text] [Related]
3. Cystic Fibrosis, CFTR, and Colorectal Cancer. Scott P; Anderson K; Singhania M; Cormier R Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326161 [TBL] [Abstract][Full Text] [Related]
5. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation. Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699 [TBL] [Abstract][Full Text] [Related]
6. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
7. BCL9-2 promotes early stages of intestinal tumor progression. Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997 [TBL] [Abstract][Full Text] [Related]
8. Role of ion channels in gastrointestinal cancer. Anderson KJ; Cormier RT; Scott PM World J Gastroenterol; 2019 Oct; 25(38):5732-5772. PubMed ID: 31636470 [TBL] [Abstract][Full Text] [Related]
9. Ap4 is rate limiting for intestinal tumor formation by controlling the homeostasis of intestinal stem cells. Jaeckel S; Kaller M; Jackstadt R; Götz U; Müller S; Boos S; Horst D; Jung P; Hermeking H Nat Commun; 2018 Sep; 9(1):3573. PubMed ID: 30177706 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Reichling T; Goss KH; Carson DJ; Holdcraft RW; Ley-Ebert C; Witte D; Aronow BJ; Groden J Cancer Res; 2005 Jan; 65(1):166-76. PubMed ID: 15665292 [TBL] [Abstract][Full Text] [Related]
11. Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. Bijvelds MJ; Bot AG; Escher JC; De Jonge HR Gastroenterology; 2009 Sep; 137(3):976-85. PubMed ID: 19454284 [TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome. Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416 [TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes. Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537 [TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide modulates cystic fibrosis transmembrane conductance regulator chloride channel expression in rat proximal colon and human intestinal epithelial cells. Novaira HJ; Ornellas DS; Ortiga-Carvalho TM; Zhang XM; Souza-Menezes J; Guggino SE; Guggino WB; Morales MM J Endocrinol; 2006 Apr; 189(1):155-65. PubMed ID: 16614390 [TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene. Du M; Jones JR; Lanier J; Keeling KM; Lindsey JR; Tousson A; Bebök Z; Whitsett JA; Dey CR; Colledge WH; Evans MJ; Sorscher EJ; Bedwell DM J Mol Med (Berl); 2002 Sep; 80(9):595-604. PubMed ID: 12226741 [TBL] [Abstract][Full Text] [Related]
17. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
18. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis. Liu S; Tackmann NR; Yang J; Zhang Y Oncogene; 2017 Mar; 36(10):1374-1383. PubMed ID: 27617574 [TBL] [Abstract][Full Text] [Related]
19. Winter M; Rokavec M; Hermeking H Cancer Res; 2021 Jul; 81(13):3621-3634. PubMed ID: 34224368 [TBL] [Abstract][Full Text] [Related]